Advantages and limitations of cytogenetic, molecular cytogenetic, and molecular diagnostic testing in mesenchymal neoplasms
Open Access
- 1 May 2008
- journal article
- other
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 13 (3) , 273-282
- https://doi.org/10.1007/s00776-007-1215-1
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcomaCancer Genetics and Cytogenetics, 2004
- Updates on cytogenetics and molecular genetics of bone and soft tissue tumors:Cancer Genetics and Cytogenetics, 2000
- Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumorsSkeletal Radiology, 2000
- Trisomies 8 and 20 Characterize a Subgroup of Benign Fibrous Lesions Arising in Both Soft Tissue and BoneThe American Journal of Pathology, 1999
- Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22The Journal of Pathology, 1998
- Karyotyping human chromosomes by combinatorial multi-fluor FISHNature Genetics, 1996
- Diagnostic Relevance of Clonal Cytogenetic Aberrations in Malignant Soft-Tissue TumorsNew England Journal of Medicine, 1991
- New chromosome techniques in the study of human neoplasiaHuman Pathology, 1981
- Banding in Human Chromosomes treated with TrypsinNature New Biology, 1972
- A RAPID BANDING TECHNIQUE FOR HUMAN CHROMOSOMESThe Lancet, 1971